Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 27, 2017 07:30 ET | Source: Strongbridge Biopharma plc

Strongbridge Biopharma plc Provides Corporate Update and Reports Full-Year 2016 Financial Results

DUBLIN, Ireland and TREVOSE, Pa., March 27, 2017 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq:SBBP), a global commercial-stage biopharmaceutical company focused on the development and...
March 17, 2017 07:30 ET | Source: Strongbridge Biopharma plc

Strongbridge Biopharma plc Announces New Employment Inducement Awards

DUBLIN, Ireland and TREVOSE, Pa., March 17, 2017 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq:SBBP), a global commercial-stage biopharmaceutical company focused on the development and...
March 14, 2017 07:30 ET | Source: Strongbridge Biopharma plc

Strongbridge Biopharma plc to Present at the 27th Annual Oppenheimer Healthcare Conference and the 16th Annual Needham Healthcare Conference

DUBLIN, Ireland and TREVOSE, Pa., March 14, 2017 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq:SBBP), a global commercial-stage biopharmaceutical company focused on the development and...
February 27, 2017 07:30 ET | Source: Strongbridge Biopharma plc

Strongbridge Biopharma plc to Present at the 37th Annual Cowen and Company Healthcare Conference and the 29th Annual ROTH Conference

DUBLIN, Ireland and TREVOSE, Pa., Feb. 27, 2017 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq:SBBP), a global commercial-stage biopharmaceutical company focused on the development and...
February 24, 2017 07:30 ET | Source: Strongbridge Biopharma plc

Strongbridge Biopharma plc Announces Annual General Meeting of Shareholders

DUBLIN, Ireland and TREVOSE, Pa., Feb. 24, 2017 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq:SBBP), a global commercial-stage biopharmaceutical company focused on the development and...
February 02, 2017 16:05 ET | Source: Strongbridge Biopharma plc

Strongbridge Biopharma plc to Participate in the Canaccord Genuity Rare Disease and BioPharma One-on-One Day

DUBLIN, Ireland and TREVOSE, Pa., Feb. 02, 2017 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq:SBBP), a global commercial-stage biopharmaceutical company focused on the development and...
January 09, 2017 07:30 ET | Source: Strongbridge Biopharma plc

Strongbridge Biopharma plc Expands Commercial Capabilities with Two Rare Disease Executive Hires

DUBLIN, Ireland and TREVOSE, Pa., Jan. 09, 2017 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq:SBBP), a global commercial-stage biopharmaceutical company focused on the development and...
January 04, 2017 07:30 ET | Source: Strongbridge Biopharma plc

Strongbridge Biopharma plc to Present at Biotech Showcase 2017

DUBLIN, Ireland and TREVOSE, Pa., Jan. 04, 2017 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq:SBBP), a global commercial-stage biopharmaceutical company focused on the development and...
December 29, 2016 09:00 ET | Source: Strongbridge Biopharma plc

Strongbridge Biopharma plc Announces Closing of $35 Million Equity Financing and $40 Million Credit Facility

DUBLIN, Ireland and TREVOSE, Pa., Dec. 29, 2016 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq:SBBP), a global commercial-stage biopharmaceutical company focused on the development and...
December 23, 2016 08:03 ET | Source: Strongbridge Biopharma plc

Strongbridge Biopharma plc Provides Corporate and Financial Update

~ Expands Rare Disease Portfolio through Acquisition of U.S. Rights to KEVEYIS®, the First and Only FDA-Approved Treatment for Hyperkalemic, Hypokalemic, and Related Variants of Primary Periodic...